Primary Hyperoxaluria-The Patient and Caregiver Perspective.
Primary Hyperoxaluria-The Patient and Caregiver Perspective. The Kidney Health Initiative, in partnership with the Oxalosis and Hyperoxaluria Foundation, convened a diverse workgroup to identify PH end points that included caregivers of people with PH, pharmaceutical representatives, researchers, and the FDA. The workgroup identified four end points that pharmaceutical companies can use in PH clinical trials. Because of this, people with PH can have hope that new treatments will be developed and approved.